Showing results (441-450 of 575) with videos related to
Sort By:
Pageof 58
FEMS Microbiology Letters|July 22, 1998
Engineering the luxCDABE genes from Photorhabdus luminescens to provide a bioluminescent reporter for constitutive and promoter probe plasmids and mini-Tn5 constructsM K Winson, S Swift, P J Hill, et al.Nature Communications|August 18, 2021
High-harmonic generation in metallic titanium nitrideA Korobenko, S Saha, A T K Godfrey, et al.Circulation|November 11, 1999
Attainment and maintenance of platelet inhibition through standard dosing of abciximab in diabetic and nondiabetic patients undergoing percutaneous coronary interventionS R Steinhubl, K Kottke-Marchant, D J Moliterno, et al.The Journal of Oral Implantology|May 1, 2001
Light microscopic and scanning electron microscopic retrieval analyses of implanted biomaterials retrieved from humans and experimental animalsD E Steflik, R S Corpe, T R Young, et al.Carbohydrate Polymers|August 13, 2016
Determining the extent of heparan sulfate depolymerisation following heparin lyase treatmentSusan M Carnachan, Tracey J Bell, Ian M Sims, et al.Journal of Cell Science|November 5, 1999
Role of alpha(v)beta(3) integrin in osteoclast migration and formation of the sealing zoneI Nakamura, M F Pilkington, P T Lakkakorpi, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 1, 1994
Murine osteoclasts and spleen cell polykaryons are distinguished by mRNA phenotypingH S Tong, D D Sakai, S M Sims, et al.Small (Weinheim an Der Bergstrasse, Germany)|April 11, 2025
Analytical Ultracentrifugation Characterization of Differential Sedimentation Size-Separated Graphene DispersionsChristopher M Sims, Jason P Killgore, Elisabeth Mansfield, et al.Journal of Human Hypertension|June 8, 2017
Psychosocial correlates of apparent treatment-resistant hypertension in the Jackson Heart StudyA J Shallcross, M Butler, R M Tanner, et al.International Journal of Peptide and Protein Research|June 1, 1996
Solution structure of a biologically active cyclic LDV peptide analogue containing a type II' beta-turn mimeticP M Doyle, J C Harris, C M Moody, et al.Pageof 58